Microwave ablation of renal tumors: A narrative review of technical considerations and clinical results.

作者: F.H. Cornelis , C. Marcelin , J.-C. Bernhard

DOI: 10.1016/J.DIII.2016.12.002

关键词: Interventional imagingRenal ablationCryoablationSurgeryRadiologyMicrowave ablationEnglish languageMedicineRadiofrequency ablationAblationNarrative review

摘要: Abstract Purpose The purpose of this review was to identify the specific technical considerations adequately perform microwave ablations (MWA) renal tumors and analyze currently available clinical results. Methods Using Medline , a systematic performed including articles published between January 2000 September 2016. English language original articles, reviews editorials were selected based on their relevance. Results MWA has several theoretical advantages over radiofrequency ablation in consistently providing higher intratumoral temperatures. is less dependent electrical conductivities tissues delivered energy limited by desiccation heated tissues. While there are insufficient data, especially because lack studies with mid- long-term follow-up, determine oncologic effectiveness MWA, technique appears safe effective for T1 tumors. There evidence using mid-level settings experimental data. Power set at 50–65 W 5–15 min adequate kidney but close imaging follow-up have be performed. Conclusion Renal offers comparison other techniques treat However, suffers cumulative data compared or cryoablation. Moreover, microwaves still require further optimal tumor characteristics device leading predictable ablation.

参考文章(64)
T. de Baere, L. Tselikas, E. Pearson, S. Yevitch, V. Boige, D. Malka, M. Ducreux, D. Goere, D. Elias, F. Nguyen, F. Deschamps, Interventional oncology for liver and lung metastases from colorectal cancer: The current state of the art. Diagnostic and interventional imaging. ,vol. 96, pp. 647- 654 ,(2015) , 10.1016/J.DIII.2015.04.004
Anna J. Moreland, Timothy J. Ziemlewicz, Sara L. Best, J. Louis Hinshaw, Meghan G. Lubner, Marci L. Alexander, Christopher L. Brace, Douglas R. Kitchin, Sean P. Hedican, Stephen Y. Nakada, Fred T. Lee, E. Jason Abel, High-powered microwave ablation of t1a renal cell carcinoma: safety and initial clinical evaluation. Journal of Endourology. ,vol. 28, pp. 1046- 1052 ,(2014) , 10.1089/END.2014.0190
Muneeb Ahmed, Gaurav Kumar, Marwan Moussa, Yuanguo Wang, Nir Rozenblum, Eithan Galun, S. Nahum Goldberg, Hepatic Radiofrequency Ablation–induced Stimulation of Distant Tumor Growth Is Suppressed by c-Met Inhibition Radiology. ,vol. 279, pp. 103- 117 ,(2016) , 10.1148/RADIOL.2015150080
S. Nahum Goldberg, G. Scott Gazelle, Peter R. Mueller, Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. American Journal of Roentgenology. ,vol. 174, pp. 323- 331 ,(2000) , 10.2214/AJR.174.2.1740323
H. H. Pennes, Analysis of Tissue and Arterial Blood Temperatures in the Resting Human Forearm Journal of Applied Physiology. ,vol. 85, pp. 5- 34 ,(1948) , 10.1152/JAPPL.1998.85.1.5
Christopher L. Brace, Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? Current Problems in Diagnostic Radiology. ,vol. 38, pp. 135- 143 ,(2009) , 10.1067/J.CPRADIOL.2007.10.001
Seong Kuk Yoon, Jong Cheol Choi, Jin Han Cho, Jong Young Oh, Kyung Jin Nam, Sae Il Jung, Hyuk Chan Kwon, Dae Cheol Kim, Seo Hee Rha, Radiofrequency Ablation of Renal VX2 Tumors With and Without Renal Artery Occlusion in a Rabbit Model: Feasibility, Therapeutic Efficacy, and Safety CardioVascular and Interventional Radiology. ,vol. 32, pp. 1241- 1246 ,(2009) , 10.1007/S00270-009-9621-8
Thomas J. Vogl, Nagy N.N. Naguib, Thomas Lehnert, Nour-Eldin A. Nour-Eldin, Radiofrequency, microwave and laser ablation of pulmonary neoplasms: clinical studies and technical considerations--review article. European Journal of Radiology. ,vol. 77, pp. 346- 357 ,(2011) , 10.1016/J.EJRAD.2009.07.034
Scott M. Castle, Nelson Salas, Raymond J. Leveillee, Initial experience using microwave ablation therapy for renal tumor treatment: 18-month follow-up. Urology. ,vol. 77, pp. 792- 797 ,(2011) , 10.1016/J.UROLOGY.2010.12.028